Trial Profile
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Laryngopharyngeal reflux
- Focus Therapeutic Use
- 30 Jun 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 08 Apr 2011 New trial record